Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2016 | Ginkgo biloba extract EGb 761® for cognitive impairment: clinical data

Amos Korczyn • 29 May 2016
EAN 2016
Mild Cognitive Impairment

At the 2nd Congress of the European Academy of Neurology (EAN), held in Copenhagen, Denmark, from May 28–31 2016, Amos Korczyn, MD, MSc, from Tel Aviv University, Ramat Aviv, Israel, reviews the current clinical evidence of the efficacy and safety of Ginkgo biloba extract EGb 761® for patients with cognitive impairment.

More from Amos Korczyn

2:53
The concept of Alzheimer's disease
Amos Korczyn • 9 Mar 2023

Related Videos

2:04
Challenges in diagnosing dementia in Asian countries
Xin Xu • 19 Jul 2023
1:11
Neurological health and dementia in China after COVID lockdowns
Xin Xu • 19 Jul 2023
1:47
Exercise as a non-pharmacological therapy for cognitive impairment
Ryan Falck • 18 Jul 2023
2:06
Use of machine learning to identify signs of cognitive decline
Ryan Falck • 18 Jul 2023
The content of VJDementia is intended for healthcare professionals